ACT vs EW · P/E 9.3, rev $1.20B vs P/E 47, rev $1.39B
Enact Holdings Inc (ACT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Enact Holdings Inc (ACT) is a insurance - specialty company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ACT revenue for 2024-12-31 was $1.20B. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. ACT currently screens at market cap $5.99B and trailing P/E 9.3.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ACT currently screens at market cap $5.99B and trailing P/E 9.3. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ACT and EW stock pages for the full models.
Not investment advice.